A client comes to the primary healthcare clinic and reports that her current sexual partner was recently diagnosed with gonorrhea. Which treatment would you expect the client and her partner to receive?

Choice A rationale The recommended first-line treatment for uncomplicated gonorrhea is typically a single 500 mg intramuscular (IM) injection of Ceftriaxone, a third-generation cephalosporin. This regimen is highly effective because Ceftriaxone achieves high, sustained serum and tissue levels and addresses the increasing rates of antimicrobial resistance seen in Neisseria gonorrhoeae, providing a reliable, single-dose cure to both the client and their partner. Choice B rationale Doxycycline is primarily used to treat Chlamydia trachomatis infection, which frequently co-occurs with gonorrhea. While it may be administered alongside Ceftriaxone for dual coverage if chlamydia hasn't been ruled out, it is not the monotherapy for gonorrhea, which requires the higher efficacy of a cephalosporin like Ceftriaxone due to resistance patterns. Choice C rationale Penicillin is no longer the standard treatment for gonorrhea because Neisseria gonorrhoeae has developed widespread resistance to penicillins and many other older antibiotics through plasmid-mediated β-lactamase production and chromosomal mutations. Using a single dose of Penicillin would likely result in treatment failure and the progression of the infection, thus necessitating the use of the more potent Ceftriaxone. Choice D rationale Gonorrhea is caused by the bacterium Neisseria gonorrhoeae and is a serious sexually transmitted infection (STI) that requires prompt antibiotic treatment. It does not typically resolve on its own. Untreated infection can lead to severe complications, including pelvic inflammatory disease (PID) in women, epididymitis in men, and potentially disseminated gonococcal infection (DGI), highlighting the necessity of effective treatment.